NHTC – Natural Health Trends Corp.

Float Short %

0.47

Margin Of Safety %

Put/Call OI Ratio

1.11

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

3.85

Target Price

Analyst Recom

Performance Q

-14.86

Relative Volume

0.27

Beta

0.8

Ticker: NHTC

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	NHTC	3.33	1.17	0.00	405
2025-12-29	NHTC	3.18	1.14	0.00	409
2025-12-30	NHTC	3.13	1.14	0.00	409
2025-12-31	NHTC	3.04	1.16	0.50	406
2026-01-02	NHTC	3.1	1.16	1.00	406
2026-01-05	NHTC	3.27	1.15	0.00	407
2026-01-06	NHTC	3.18	1.15	0.59	408
2026-01-07	NHTC	3.29	1.15	0.59	408
2026-01-08	NHTC	3.26	1.09	0.00	442
2026-01-09	NHTC	3.34	1.09	999.99	442
2026-01-12	NHTC	3.4	1.18	0.00	459
2026-01-13	NHTC	3.52	1.18	0.00	459
2026-01-14	NHTC	3.63	1.18	0.00	459
2026-01-15	NHTC	3.69	1.16	0.00	462
2026-01-16	NHTC	3.69	1.16	0.00	462
2026-01-20	NHTC	3.87	1.40	0.00	394
2026-01-21	NHTC	3.81	1.38	0.00	397
2026-01-22	NHTC	3.83	1.11	0.00	438
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	NHTC	3.26	-	-	-
2025-12-29	NHTC	3.17	-	-	-
2025-12-30	NHTC	3.13	-	-	-
2025-12-31	NHTC	3.09	-	-	-
2026-01-02	NHTC	3.12	-	-	-
2026-01-05	NHTC	3.25	-	-	-
2026-01-06	NHTC	3.21	-	-	-
2026-01-07	NHTC	3.29	-	-	-
2026-01-08	NHTC	3.29	-	-	-
2026-01-09	NHTC	3.34	-	-	-
2026-01-12	NHTC	3.48	-	-	-
2026-01-13	NHTC	3.46	-	-	-
2026-01-14	NHTC	3.67	-	-	-
2026-01-15	NHTC	3.68	-	-	-
2026-01-16	NHTC	3.62	-	-	-
2026-01-20	NHTC	3.92	-	-	-
2026-01-21	NHTC	3.76	-	-	-
2026-01-22	NHTC	3.85	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	NHTC	0.00	-17.42	0.72
2025-12-29	NHTC	0.00	-17.51	0.72
2025-12-30	NHTC	0.00	-17.51	0.72
2025-12-31	NHTC	0.00	-17.51	0.72
2026-01-02	NHTC	0.00	-17.51	0.72
2026-01-05	NHTC	0.00	-17.51	0.72
2026-01-06	NHTC	0.00	-17.51	0.72
2026-01-07	NHTC	0.00	-17.51	0.72
2026-01-08	NHTC	0.00	-17.51	0.72
2026-01-09	NHTC	0.00	-17.51	0.72
2026-01-12	NHTC	0.00	-17.51	0.72
2026-01-13	NHTC	0.00	-17.51	0.47
2026-01-14	NHTC	0.00	-17.51	0.47
2026-01-15	NHTC	0.00	-17.51	0.47
2026-01-16	NHTC	0.00	-17.51	0.47
2026-01-20	NHTC	0.00	-17.51	0.47
2026-01-21	NHTC	0.00	-17.51	0.47
2026-01-22	NHTC	0.00	-17.51	0.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-17.51

Beta

0.8

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-58.9

Target Price

P/E

Forward P/E

PEG

P/S

1.08

P/B

1.69

P/Free Cash Flow

EPS

-0.01

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-0.29

Relative Volume

0.27

Return on Equity vs Sector %

-19.1

Return on Equity vs Industry %

-20.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Natural Health Trends Corp. - C

Sector: Consumer Cyclical

Industry: Internet Retail

Employees: 133

Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, such as liquid, encapsulated, tableted and powder dietary and nutritional supplements, vitamins, and minerals; and herbal products, including herbal supplements. It also provides beauty products comprising age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products consisting of weight management and energy enhancing supplements, as well as topical gels. In addition, the company offers home appliances; daily products, such as oral, hair, and body care products; and at-home testing kits for measuring critical biomarkers of well-being, including cardiovascular, hormonal, inflammatory, metabolic, and nutritional health. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, the Cayman Islands, Mexico, Peru, and Colombia; Hong Kong, Taiwan, and China; Malaysia and Singapore; South Korea; Russia and Kazakhstan; Japan; India; and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Rolling Hills Estates, California.

stock quote shares NHTC – Natural Health Trends Corp. Stock Price stock today

news today NHTC – Natural Health Trends Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch NHTC – Natural Health Trends Corp. yahoo finance google finance

stock history NHTC – Natural Health Trends Corp. invest stock market

stock prices NHTC premarket after hours

ticker NHTC fair value insiders trading

MSC – Studio City International Holdings Ltd ADR

Float Short %

0.01

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

3.26

Target Price

Analyst Recom

Performance Q

-19.21

Relative Volume

0.52

Beta

-0.05

Ticker: MSC

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	MSC	2.95	N/A	N/A	0
2025-12-29	MSC	3.45	N/A	N/A	0
2025-12-30	MSC	3.5	N/A	N/A	0
2025-12-31	MSC	3.58	N/A	N/A	0
2026-01-02	MSC	3.53	N/A	N/A	0
2026-01-05	MSC	3.31	N/A	N/A	0
2026-01-06	MSC	3.49	N/A	N/A	0
2026-01-07	MSC	3.37	N/A	N/A	0
2026-01-08	MSC	3.48	N/A	N/A	0
2026-01-09	MSC	3.48	N/A	N/A	0
2026-01-12	MSC	3.52	N/A	N/A	0
2026-01-13	MSC	3.34	N/A	N/A	0
2026-01-14	MSC	3.35	N/A	N/A	0
2026-01-15	MSC	3.3	N/A	N/A	0
2026-01-16	MSC	3.15	N/A	N/A	0
2026-01-20	MSC	3.44	N/A	N/A	0
2026-01-21	MSC	3.53	N/A	N/A	0
2026-01-22	MSC	3.25	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	MSC	2.93	-	-	-
2025-12-29	MSC	3.53	-	-	-
2025-12-30	MSC	3.69	-	-	-
2025-12-31	MSC	3.67	-	-	-
2026-01-02	MSC	3.51	-	-	-
2026-01-05	MSC	3.31	-	-	-
2026-01-06	MSC	3.49	-	-	-
2026-01-07	MSC	3.36	-	-	-
2026-01-08	MSC	3.50	-	-	-
2026-01-09	MSC	3.48	-	-	-
2026-01-12	MSC	3.48	-	-	-
2026-01-13	MSC	3.48	-	-	-
2026-01-14	MSC	3.35	-	-	-
2026-01-15	MSC	3.66	-	-	-
2026-01-16	MSC	3.18	-	-	-
2026-01-20	MSC	3.53	-	-	-
2026-01-21	MSC	3.58	-	-	-
2026-01-22	MSC	3.26	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	MSC	0	-7.66	0.00
2025-12-29	MSC	0	-7.66	0.00
2025-12-30	MSC	0	-7.66	0.00
2025-12-31	MSC	0	-7.66	0.00
2026-01-02	MSC	0	-7.66	0.00
2026-01-05	MSC	0	-7.66	0.00
2026-01-06	MSC	0	-7.66	0.00
2026-01-07	MSC	0	-7.66	0.00
2026-01-08	MSC	0	-7.66	0.00
2026-01-09	MSC	0	-7.66	0.00
2026-01-12	MSC	0	-7.66	0.00
2026-01-13	MSC	0	-7.66	0.01
2026-01-14	MSC	0	-7.66	0.01
2026-01-15	MSC	0	-7.66	0.01
2026-01-16	MSC	0	-7.66	0.01
2026-01-20	MSC	0	-7.66	0.01
2026-01-21	MSC	0	-7.66	0.01
2026-01-22	MSC	0	-7.66	0.01
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-7.66

Beta

-0.05

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

79.6

Max Drawdown 5-Year %

-90.3

Target Price

P/E

Forward P/E

PEG

P/S

0.91

P/B

1.26

P/Free Cash Flow

EPS

-0.34

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.61

Relative Volume

0.52

Return on Equity vs Sector %

-29.7

Return on Equity vs Industry %

-39.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Studio City International Holdi

Sector: Consumer Cyclical

Industry: Resorts & Casinos

Employees: 5848

Studio City International Holdings Limited provides provision of services pursuant to a casino contract and the hospitality business in Macau. It operates Studio City Casino, comprising gaming tables, including tables for VIP rolling chip operations and gaming machines; and resort, which offers various non-gaming attractions, including figure-8 ferris wheel, night club and karaoke venue, live performance arena, and an outdoor and indoor water park, as well as live performance arena and various food and beverage establishments, and retail space. The company was formerly known as Cyber One Agents Limited and changed its name to Studio City International Holdings Limited in January 2012. The company was founded in 2000 and is based in Central, Hong Kong. Studio City International Holdings Limited is a subsidiary of MCO Cotai Investments Limited.

stock quote shares MSC – Studio City International Holdings Ltd ADR Stock Price stock today

news today MSC – Studio City International Holdings Ltd ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch MSC – Studio City International Holdings Ltd ADR yahoo finance google finance

stock history MSC – Studio City International Holdings Ltd ADR invest stock market

stock prices MSC premarket after hours

ticker MSC fair value insiders trading

FUTU – Futu Holdings Limited

Float Short %

5.17

Margin Of Safety %

Put/Call OI Ratio

1.52

EPS Next Q Diff

EPS Last/This Y

72.95

EPS This/Next Y

10.96

Price

161.94

Target Price

229.88

Analyst Recom

1.19

Performance Q

-4.26

Relative Volume

1.18

Beta

0.42

Ticker: FUTU

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	FUTU	165.22	1.32	0.83	149956
2025-12-29	FUTU	165.9	1.32	0.85	147452
2025-12-30	FUTU	165.27	1.33	2.77	148510
2025-12-31	FUTU	164.27	1.34	3.69	149688
2026-01-02	FUTU	178.43	1.34	0.64	150415
2026-01-05	FUTU	180.99	1.33	0.55	149349
2026-01-06	FUTU	180.3	1.33	0.74	150814
2026-01-07	FUTU	177.05	1.33	0.63	152187
2026-01-08	FUTU	180.11	1.34	1.13	152722
2026-01-09	FUTU	178.49	1.35	1.41	153554
2026-01-12	FUTU	188.26	1.37	0.48	150669
2026-01-13	FUTU	184.22	1.34	1.01	155538
2026-01-14	FUTU	174.1	1.35	1.01	156686
2026-01-15	FUTU	176.59	1.36	1.81	158809
2026-01-16	FUTU	171.8	1.38	1.09	160221
2026-01-20	FUTU	170.68	1.56	0.90	68600
2026-01-21	FUTU	165.94	1.53	0.93	70467
2026-01-22	FUTU	161.96	1.52	1.24	71772
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	FUTU	165.10	76.7	-	78.02
2025-12-29	FUTU	166.06	76.7	-	78.02
2025-12-30	FUTU	165.23	76.7	-	78.02
2025-12-31	FUTU	164.20	76.7	-	78.02
2026-01-02	FUTU	178.47	76.7	-	78.02
2026-01-05	FUTU	180.99	76.7	-	78.02
2026-01-06	FUTU	180.27	76.7	-	78.02
2026-01-07	FUTU	177.08	76.7	-	78.02
2026-01-08	FUTU	179.99	76.7	-	78.02
2026-01-09	FUTU	178.49	76.7	-	78.02
2026-01-12	FUTU	188.20	76.7	-	78.02
2026-01-13	FUTU	184.23	76.7	-	78.02
2026-01-14	FUTU	174.13	76.7	-	78.02
2026-01-15	FUTU	176.55	76.7	-	78.02
2026-01-16	FUTU	171.60	76.7	-	78.02
2026-01-20	FUTU	170.68	76.7	-	78.02
2026-01-21	FUTU	166.05	76.7	-	78.02
2026-01-22	FUTU	161.94	76.7	-	78.02
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	FUTU	0.00	12.27	5.37
2025-12-29	FUTU	0.00	12.27	5.37
2025-12-30	FUTU	0.00	12.27	5.37
2025-12-31	FUTU	0.00	12.27	5.37
2026-01-02	FUTU	0.00	12.27	5.37
2026-01-05	FUTU	0.00	12.47	5.37
2026-01-06	FUTU	0.00	12.47	5.37
2026-01-07	FUTU	0.00	12.47	5.37
2026-01-08	FUTU	0.00	12.47	5.37
2026-01-09	FUTU	0.00	12.47	5.37
2026-01-12	FUTU	0.00	12.48	5.37
2026-01-13	FUTU	0.00	12.48	5.17
2026-01-14	FUTU	0.00	12.48	5.17
2026-01-15	FUTU	0.00	12.48	5.17
2026-01-16	FUTU	0.00	12.48	5.17
2026-01-20	FUTU	0.00	14.11	5.17
2026-01-21	FUTU	0.00	14.11	5.17
2026-01-22	FUTU	0.00	14.11	5.17
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

24.61

Avg. EPS Est. Next Quarter

26.71

Insider Transactions

Institutional Transactions

14.11

Beta

0.42

Average Sales Estimate Current Quarter

5664

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

100

Sentiment Score

Actual DrawDown %

20.7

Max Drawdown 5-Year %

-87.2

Target Price

229.88

P/E

18.1

Forward P/E

15.6

PEG

0.52

P/S

5.73

P/B

4.81

P/Free Cash Flow

EPS

8.95

Average EPS Est. Cur. Y

78.02

EPS Next Y. (Est.)

88.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

47.11

Relative Volume

1.18

Return on Equity vs Sector %

15.4

Return on Equity vs Industry %

13.4

EPS 1 7Days Diff

8.4

EPS 1 30Days Diff

10.87

EBIT Estimation

Futu Holdings Limited

Sector: Financial Services

Industry: Capital Markets

Employees: 3343

Futu Holdings Limited provides digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally. The company offers online financial services, including securities and derivative trades brokerage, margin financing and fund distribution services through its Futubull and Moomoo digital platforms. It also provides financial information and online community services; online wealth management services under the Money Plus brand name through its Futubull and moomoo platforms, which provides its client access to mutual funds, private funds, bonds, structured products, and other wealth management products; market data and information services; and NiuNiu Community, an open forum for users and clients to share insights, ask questions, and exchange ideas. Futu Holdings Limited was founded in 2007 and is headquartered in Admiralty, Hong Kong.

stock quote shares FUTU – Futu Holdings Limited Stock Price stock today

news today FUTU – Futu Holdings Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch FUTU – Futu Holdings Limited yahoo finance google finance

stock history FUTU – Futu Holdings Limited invest stock market

stock prices FUTU premarket after hours

ticker FUTU fair value insiders trading

HCM – HUTCHMED (China) Limited

Float Short %

0.22

Margin Of Safety %

Put/Call OI Ratio

0.46

EPS Next Q Diff

EPS Last/This Y

1.25

EPS This/Next Y

-1.05

Price

15.53

Target Price

23.58

Analyst Recom

1.2

Performance Q

1.58

Relative Volume

1.26

Beta

0.41

Ticker: HCM

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	HCM	13.74	0.47	999.99	267
2025-12-29	HCM	13.34	0.47	0.20	268
2025-12-30	HCM	13.15	0.48	0.00	269
2025-12-31	HCM	13.33	0.48	0.00	269
2026-01-02	HCM	13.7	0.47	0.00	272
2026-01-05	HCM	13.33	0.47	999.99	273
2026-01-06	HCM	13.74	0.47	0.00	274
2026-01-07	HCM	14.66	0.44	0.00	289
2026-01-08	HCM	14.78	0.42	0.00	296
2026-01-09	HCM	14.72	0.41	999.99	301
2026-01-12	HCM	14.87	0.42	0.06	302
2026-01-13	HCM	14.97	0.38	0.00	317
2026-01-14	HCM	15.3	0.38	0.00	317
2026-01-15	HCM	15.31	0.38	0.00	317
2026-01-16	HCM	16.02	0.38	5.50	318
2026-01-20	HCM	15.76	0.46	4.00	315
2026-01-21	HCM	15.81	0.46	4.00	315
2026-01-22	HCM	15.53	0.46	4.00	315
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	HCM	13.72	-	-77.2	1.45
2025-12-29	HCM	13.35	-	-72.0	1.45
2025-12-30	HCM	13.25	-	-65.6	1.45
2025-12-31	HCM	13.30	-	-65.0	1.45
2026-01-02	HCM	13.77	-	-68.4	1.45
2026-01-05	HCM	13.38	-	-63.2	1.45
2026-01-06	HCM	13.73	-	-70.6	1.45
2026-01-07	HCM	14.66	-	-77.6	1.45
2026-01-08	HCM	14.81	-	-74.8	1.45
2026-01-09	HCM	14.67	-	-72.3	1.45
2026-01-12	HCM	14.90	-	-74.2	1.45
2026-01-13	HCM	14.98	-	-71.4	1.45
2026-01-14	HCM	15.23	-	-74.3	1.45
2026-01-15	HCM	15.30	-	-80.3	1.45
2026-01-16	HCM	16.09	-	-77.2	1.45
2026-01-20	HCM	15.75	-	-70.4	1.45
2026-01-21	HCM	15.81	-	-76.1	1.45
2026-01-22	HCM	15.53	-	-68.2	1.45
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	HCM	0.00	-0.11	0.23
2025-12-29	HCM	0.00	-0.12	0.23
2025-12-30	HCM	0.00	-0.12	0.23
2025-12-31	HCM	0.00	-0.12	0.23
2026-01-02	HCM	0.00	-0.12	0.23
2026-01-05	HCM	0.00	0.50	0.23
2026-01-06	HCM	0.00	0.50	0.23
2026-01-07	HCM	0.00	0.50	0.23
2026-01-08	HCM	0.00	0.50	0.23
2026-01-09	HCM	0.00	0.50	0.23
2026-01-12	HCM	0.00	0.49	0.23
2026-01-13	HCM	0.00	0.49	0.22
2026-01-14	HCM	0.00	0.49	0.22
2026-01-15	HCM	0.00	0.49	0.22
2026-01-16	HCM	0.00	0.49	0.22
2026-01-20	HCM	0.00	0.65	0.22
2026-01-21	HCM	0.00	0.65	0.22
2026-01-22	HCM	0.00	0.65	0.22
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.65

Beta

0.41

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

64.7

Max Drawdown 5-Year %

-82.2

Target Price

23.58

P/E

5.76

Forward P/E

60.7

PEG

2.25

P/S

4.46

P/B

2.19

P/Free Cash Flow

EPS

2.68

Average EPS Est. Cur. Y

1.45

EPS Next Y. (Est.)

0.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

77.54

Relative Volume

1.26

Return on Equity vs Sector %

10.7

Return on Equity vs Industry %

30.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-68.2

HUTCHMED (China) Limited

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1780

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

stock quote shares HCM – HUTCHMED (China) Limited Stock Price stock today

news today HCM – HUTCHMED (China) Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch HCM – HUTCHMED (China) Limited yahoo finance google finance

stock history HCM – HUTCHMED (China) Limited invest stock market

stock prices HCM premarket after hours

ticker HCM fair value insiders trading

MLCO – Melco Resorts & Entertainment Limited

Float Short %

1.75

Margin Of Safety %

Put/Call OI Ratio

0.6

EPS Next Q Diff

-0.05

EPS Last/This Y

0.46

EPS This/Next Y

0.12

Price

6.34

Target Price

10.15

Analyst Recom

1.92

Performance Q

-22.02

Relative Volume

2.1

Beta

0.64

Ticker: MLCO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	MLCO	8.01	0.26	0.35	40384
2025-12-29	MLCO	7.82	0.27	8.05	39568
2025-12-30	MLCO	7.6	0.28	0.10	39916
2025-12-31	MLCO	7.56	0.28	0.34	39869
2026-01-02	MLCO	7.5	0.28	1.38	40239
2026-01-05	MLCO	7.53	0.28	0.75	39636
2026-01-06	MLCO	7.53	0.28	0.20	39725
2026-01-07	MLCO	6.98	0.28	0.42	40010
2026-01-08	MLCO	6.88	0.27	1.03	40499
2026-01-09	MLCO	6.64	0.27	0.38	40712
2026-01-12	MLCO	6.71	0.28	1.06	40268
2026-01-13	MLCO	6.58	0.20	0.05	38086
2026-01-14	MLCO	6.7	0.20	8.38	38300
2026-01-15	MLCO	6.74	0.37	0.88	44677
2026-01-16	MLCO	6.11	0.37	7.01	45121
2026-01-20	MLCO	6.22	0.62	0.47	20041
2026-01-21	MLCO	6.03	0.61	0.46	20490
2026-01-22	MLCO	6.34	0.60	0.15	21362
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	MLCO	8.01	1500.0	139.7	0.56
2025-12-29	MLCO	7.82	1500.0	130.6	0.56
2025-12-30	MLCO	7.60	1500.0	129.2	0.56
2025-12-31	MLCO	7.57	1500.0	134.7	0.56
2026-01-02	MLCO	7.51	1500.0	134.1	0.56
2026-01-05	MLCO	7.53	1500.0	136.4	0.56
2026-01-06	MLCO	7.52	1500.0	135.8	0.56
2026-01-07	MLCO	6.98	1500.0	119.7	0.56
2026-01-08	MLCO	6.88	1500.0	132.3	0.56
2026-01-09	MLCO	6.64	1500.0	128.6	0.56
2026-01-12	MLCO	6.71	1500.0	137.8	0.56
2026-01-13	MLCO	6.58	1500.0	131.7	0.56
2026-01-14	MLCO	6.69	1500.0	139.0	0.56
2026-01-15	MLCO	6.74	1500.0	137.6	0.56
2026-01-16	MLCO	6.11	1500.0	103.4	0.56
2026-01-20	MLCO	6.22	1500.0	124.9	0.56
2026-01-21	MLCO	6.03	1500.0	115.9	0.56
2026-01-22	MLCO	6.34	1500.0	131.7	0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	MLCO	0.00	-4.65	1.56
2025-12-29	MLCO	0.00	-9.10	1.56
2025-12-30	MLCO	0.00	-9.10	1.56
2025-12-31	MLCO	0.00	-9.10	1.56
2026-01-02	MLCO	0.00	-9.10	1.56
2026-01-05	MLCO	0.00	-8.94	1.56
2026-01-06	MLCO	0.00	-8.94	1.56
2026-01-07	MLCO	0.00	-8.94	1.56
2026-01-08	MLCO	0.00	-8.94	1.56
2026-01-09	MLCO	0.00	-8.94	1.56
2026-01-12	MLCO	0.00	-8.96	1.56
2026-01-13	MLCO	0.00	-8.96	1.75
2026-01-14	MLCO	0.00	-8.96	1.75
2026-01-15	MLCO	0.00	-8.96	1.75
2026-01-16	MLCO	0.00	-8.96	1.75
2026-01-20	MLCO	0.00	-6.05	1.75
2026-01-21	MLCO	0.00	-6.05	1.75
2026-01-22	MLCO	0.00	-6.05	1.75
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.21

Avg. EPS Est. Current Quarter

0.07

Avg. EPS Est. Next Quarter

0.16

Insider Transactions

Institutional Transactions

-6.05

Beta

0.64

Average Sales Estimate Current Quarter

1290

Average Sales Estimate Next Quarter

1295

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

73.2

Max Drawdown 5-Year %

-80.8

Target Price

10.15

P/E

24.12

Forward P/E

9.02

PEG

0.08

P/S

0.49

P/B

P/Free Cash Flow

EPS

0.26

Average EPS Est. Cur. Y

0.56

EPS Next Y. (Est.)

0.68

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

2.06

Relative Volume

2.1

Return on Equity vs Sector %

-26.6

Return on Equity vs Industry %

-36.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

131.7

Melco Resorts & Entertainment L

Sector: Consumer Cyclical

Industry: Resorts & Casinos

Employees: 21784

Melco Resorts & Entertainment Limited develops, owns, and operates casino gaming and resort facilities in Asia and Europe. It owns and operates City of Dreams, an integrated casino resort that has gaming tables and gaming machines; suites and villas; restaurants and bars; retail outlets; a wet stage performance theater; and recreation and leisure facilities. The company also operates Altira Macau, a casino hotel, which has gaming tables and gaming machines; hotel rooms; dining and casual restaurants; recreation and leisure facilities; and non-gaming amenities. In addition, it operates Studio City, a cinematically themed integrated resort with gaming facilities, hotel, entertainment, retail, and food and beverage outlets in Cotai, Macau. Further, the company owns and operates Mocha Clubs with gaming machines, as well as Grand Dragon casino in Taipa Island, Macau. Additionally, it operates and manages City of Dreams Manila, an integrated resort in the Entertainment City complex in Manila; a casino in Limassol and satellite casinos in Nicosia, Ayia Napa, and Paphos in Cyprus; and develops and operates City of Dreams Mediterranean, an integrated casino resort in Cyprus. The company was formerly known as Melco Crown Entertainment Limited and changed its name to Melco Resorts & Entertainment Limited in April 2017. Melco Resorts & Entertainment Limited was incorporated in 2004 and is based in Central, Hong Kong. The company operates as a subsidiary of Melco Leisure and Entertainment Group Limited.

stock quote shares MLCO – Melco Resorts & Entertainment Limited Stock Price stock today

news today MLCO – Melco Resorts & Entertainment Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch MLCO – Melco Resorts & Entertainment Limited yahoo finance google finance

stock history MLCO – Melco Resorts & Entertainment Limited invest stock market

stock prices MLCO premarket after hours

ticker MLCO fair value insiders trading

CO – Global Cord Blood Corporation

Float Short %

0.35

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.99

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

0.17

Ticker: CO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	CO	2.9876	N/A	N/A	0
2025-12-29	CO	2.9876	N/A	N/A	0
2025-12-30	CO	2.9876	N/A	N/A	0
2025-12-31	CO	2.9876	N/A	N/A	0
2026-01-02	CO	2.9876	N/A	N/A	0
2026-01-05	CO	2.9876	N/A	N/A	0
2026-01-06	CO	2.9876	N/A	N/A	0
2026-01-07	CO	2.9876	N/A	N/A	0
2026-01-08	CO	2.9876	N/A	N/A	0
2026-01-09	CO	2.9876	N/A	N/A	0
2026-01-12	CO	2.9876	N/A	N/A	0
2026-01-13	CO	2.9876	N/A	N/A	0
2026-01-14	CO	2.9876	N/A	N/A	0
2026-01-15	CO	2.9876	N/A	N/A	0
2026-01-16	CO	2.9876	N/A	N/A	0
2026-01-20	CO	2.9876	N/A	N/A	0
2026-01-21	CO	2.9876	N/A	N/A	0
2026-01-22	CO	2.9876	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

4.15

Beta

0.17

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

4.03

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

70.5

Max Drawdown 5-Year %

-79.7

Target Price

P/E

5.03

Forward P/E

PEG

0.17

P/S

1.66

P/B

0.51

P/Free Cash Flow

3.36

EPS

0.58

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

40.3

Relative Volume

Return on Equity vs Sector %

-11.9

Return on Equity vs Industry %

-2.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

stock quote shares CO – Global Cord Blood Corporation Stock Price stock today

news today CO – Global Cord Blood Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch CO – Global Cord Blood Corporation yahoo finance google finance

stock history CO – Global Cord Blood Corporation invest stock market

stock prices CO premarket after hours

ticker CO fair value insiders trading

NHTC – Natural Health Trends Corp.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NHTC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

MSC – Studio City International Holdings Ltd ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MSC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y